2006/09 - 2014/07 北京大学，眼科学，博士，导师：王薇、李学民

2013/07-2013/08 丹麦哥本哈根大学附属医院眼科 实习

2011/07-2011/08 韩国嘉泉大学Gil医院眼科 实习

主攻白内障、干眼、眼表疾病等，主要研究眼表与泪膜相关疾病的发 病机制和开发相应的新型治疗方法，发表眼表相关文章 SCI 二十余篇，其中，以第一作者发表SCI论文17篇。 在干眼强效脉冲光波治疗、抗新生血管治疗以及眼表微生物菌群失调等领域有着丰富的经验。作为Sub-I承担并参与眼科三期临床试验近十余项，完成省级基金两项，现承担并参与国家级基金一项，省级基金一项。

1、北京大学第三医院, 院重点项目, BYSYZD2021044, 以印迹细胞学联合在提共聚焦显微镜为导向的干燥 综合征无创筛查的临床应用初探, 2022-01 至 2025-12, 10万元, 在研, 主持。

2、北京市自然科学基金, 北京市自然科学基金（面上）, 7202229, MYH9基因突变导致先天性白内障及其 与F-actin蛋白网络相关性的分子机制研究, 2020-01 至 2022-12, 20万元, 结题, 参与。

3、中华人民共和国科学技术部, 国家科技重大专项, 2018ZX0101004, 东非、中亚和东南亚等区域重要传 染病防控 关键保障技术研究-东南亚地区重要传染病防控保障技术研究, 2018-01 至 2020-12, 74.3万元, 结 题, 参与。

4、北京市卫生健康委员会, 首都卫生发展科研专项（自主创新）, 首发2018-2-4093, 砭石艾灸红外干眼 治疗仪在睑板腺功能障碍治疗中的有效性及安全性研究, 2018-01 至 2020-12, 40万元, 结题, 参与。

1. Xiaodan Jiang*, Yu Wan*; Hao Yuan*; Liming Zhao*; Min Sun*; Yanhui Xu*; Xiangyang Xin*; Jing Dong*; Die Hu*; Dongmei Chen*; Xuemin Li ; Incidence, Prophylaxis and Prognosis of Acute Postoperative Endophthalmitis After Cataract Surgery: A Multicenter Retrospective Analysis in Northern China from 2013 to 2019, Infection and Drug Resistance, 2022, Volume 15(15): 4047- 4058. (IF2022=4.177, Q2)

2. Xiaodan Jiang*; Hao Yuan*; Mingzhou Zhang; Huibin Lv; Yilin Chou; Jiarui Yang; Xuemin Li ; The Efficacy and Safety of New-Generation Intense Pulsed Light in the Treatment of Meibomian Gland Dysfunction-Related Dry Eye: A Multicenter, Randomized, Patients-Blind, Parallel-Control, Non-Inferiority Clinical Trial, Ophthalmology and therapy, 2022, 11(11): 1895-1912. (IF2022=4.927, Q1)

3. Xiaodan Jiang*; Yiren Wang*; Hao Yuan; Yuanting Li; Hongmei Wang; Zhuoyu An; Xuemin Li ; Influences of SMILE and FS-LASIK on Corneal Sub-basal Nerves: A Systematic Review and Network Meta-analysis, Journal of Refractive Surgery, 2022, 38(4): 277-284. (IF2022=3.573, Q1)

4. Jiang X*, Wang Y*, Qiu W*, Huang C, Liu Z, Ding T, Shi D, Li X. Corneal Stromal Transplantation With Human-derived Acellular Dermal Matrix for Pellucid Marginal Corneal Degeneration: A Nonrandomized Clinical Trial. Transplantation. 2019 Jun;103(6):e172-e179. （IF2019=4.743，Q1）

5. Jiang X*, Wang Y*, Lv H, Liu Y, Zhang M, Li X. Efficacy of intra-meibomian gland injection of the anti-VEGF agent bevacizumab for the treatment of meibomian gland dysfunction with lid-margin vascularity. Drug Des Devel Ther. 2018 May 16;12:1269-1279.  （IF2018=3.208，Q2）

6. Jiang X*, Deng A,* Yang J*, Bai H, Yang Z, Wu J, Lv H, Li X, Wen T. Pathogens in the Meibomian gland and conjunctival sac: microbiome of normal subjects and patients with Meibomian gland dysfunction. Infect Drug Resist. 2018 Oct 11;11:1729-1740. （IF2018=3.0，Q2）

7. Jiang X*, Huibin Lv*, Weiqiang Qiu, Ziyuan Liu, Xuemin Li, Wang Wei, Efficiency and safety of subconjunctival injection of anti-VEGF agent - bevacizumab - in treating dry eye. Drug Des Devel Ther. 2015 12;9: 3043-50. （IF2015=3.208，Q2）

8. Jiang X*, Lv H*, Song H, Zhang M, Liu Y, Hu X, Li X, Wang W. Evaluation of the Safety and Effectiveness of Intense Pulsed Light in the Treatment of Meibomian Gland Dysfunction. J Ophthalmol. 2016;2016:1910694.（IF2016=1.58，Q3）

9. Dalan Jing*; Xiaodan Jiang*; Xiaotong Ren*; Jie Su*; Chen Huang; Jiarui Yang; Ran Hao; Xuemin Li ; Metagenomic nanopore sequencing of ocular microbiome in patients with meibomian gland dysfunction, Frontiers in Medicine, 2022, 9(10). (IF2022=5.058，Q2)

10. Dalan Jing*; Xiaodan Jiang*; Peng Zhou; Xiaotong Ren; Jie Su; Ran Hao; Mingzhong Zhang; Yu Wan; Xuemin Li ; Evidence of air pollution-related ocular signs and altered inflammatory cytokine profile of the ocular surface in Beijing, Scientific Reports, 2022, 12(1). (IF2022=4.996，Q2)

11. Dalan Jing*; Xiaodan Jiang*; Xiaotong Ren; Jie Su; Shanshan Wei; Ran Hao; Yilin Chou; Xuemin Li ; Change Patterns in Corneal Intrinsic Aberrations and Nerve Density after Cataract Surgery in Patients with Dry Eye Disease, Journal of Clinical Medicine, 2022, 11(19): 5697. (IF2022=4.964，Q2）

12. Dalan Jing*; Xiaodan Jiang*; Yilin Chou*; Shanshan Wei; Ran Hao; Jie Su; Xuemin Li ; In vivo Confocal Microscopic Evaluation of Previously Neglected Oval Cells in Corneal Nerve Vortex: An Inflammatory Indicator of Dry Eye Disease, Frontiers in Medicine, 2022, 9(1). (IF2022=5.058，Q2）

13. Hao Y*, Xiaodan J*, Jiarui Y, Xuemin L. The effect of hormone therapy on the ocular surface and intraocular pressure for postmenopausal women: a systematic review and meta-analysis of randomized controlled trials [published online ahead of print, 2020 Jun]. Menopause.（ IF2020=3.305，Q1）

14. Ma J*, Wei S*, Jiang X*, Chou Y, Wang Y, Hao R, Yang J, Li X. Evaluation of objective visual quality in dry eye disease and corneal nerve changes. Int Ophthalmol. 2020 Jul 2. doi: 10.1007/s10792-020-01483-5. Epub ahead of print. PMID: 32617802. （IF2020=1.496）

15. Hao R*, Chou Y*, Wan Y*, Jiang X*, Li X. Patient satisfaction with the ocular surface individualized medical program. Eur J Ophthalmol. 2020 Jul 28:1120672120945653. doi: 10.1177/1120672120945653. Epub ahead of print. PMID: 32722934. （IF2020=1.642）

16. Ren X*, Chou Y*, Jiang X*, Hao R, Wang Y, Chen Y, Li X. Effects of Oral Vitamin B1 and Mecobalamin on Dry Eye Disease. J Ophthalmol. 2020 Sep 9;2020:9539674. doi: 10.1155/2020/9539674. PMID: 33005449; PMCID: PMC7508221. (IF2020=1.447)

17. 江晓丹*，李学民. 血管内皮生长因子及贝伐单抗在小梁切除术后伤口愈合过程中的作用[J]. 中华实验眼科杂志, 2016, 34(012):1136-1139.

《干眼诊疗使用手册》 副主译 2019，8.